21 May 2013
Keywords: xeloda, plus, chemo, reduces, recurrence, data, new
Article | 22 December 2008
Data from a new study of Roche's Xeloda (capecitabine) plus standard chemotherapy show that the combination allows women to live ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2008
© 2013 thepharmaletter.com